Suppr超能文献

14名捐赠者中靶向CD4超位点的HIV-1中和抗体的结构库

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors.

作者信息

Zhou Tongqing, Lynch Rebecca M, Chen Lei, Acharya Priyamvada, Wu Xueling, Doria-Rose Nicole A, Joyce M Gordon, Lingwood Daniel, Soto Cinque, Bailer Robert T, Ernandes Michael J, Kong Rui, Longo Nancy S, Louder Mark K, McKee Krisha, O'Dell Sijy, Schmidt Stephen D, Tran Lillian, Yang Zhongjia, Druz Aliaksandr, Luongo Timothy S, Moquin Stephanie, Srivatsan Sanjay, Yang Yongping, Zhang Baoshan, Zheng Anqi, Pancera Marie, Kirys Tatsiana, Georgiev Ivelin S, Gindin Tatyana, Peng Hung-Pin, Yang An-Suei, Mullikin James C, Gray Matthew D, Stamatatos Leonidas, Burton Dennis R, Koff Wayne C, Cohen Myron S, Haynes Barton F, Casazza Joseph P, Connors Mark, Corti Davide, Lanzavecchia Antonio, Sattentau Quentin J, Weiss Robin A, West Anthony P, Bjorkman Pamela J, Scheid Johannes F, Nussenzweig Michel C, Shapiro Lawrence, Mascola John R, Kwong Peter D

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases and National Institutes of Health, Bethesda, MD 20892, USA.

Department of Biochemistry & Molecular Biophysics and Department of Systems Biology, Columbia University, New York, NY 10032, USA.

出版信息

Cell. 2015 Jun 4;161(6):1280-92. doi: 10.1016/j.cell.2015.05.007. Epub 2015 May 21.

Abstract

The site on the HIV-1 gp120 glycoprotein that binds the CD4 receptor is recognized by broadly reactive antibodies, several of which neutralize over 90% of HIV-1 strains. To understand how antibodies achieve such neutralization, we isolated CD4-binding-site (CD4bs) antibodies and analyzed 16 co-crystal structures -8 determined here- of CD4bs antibodies from 14 donors. The 16 antibodies segregated by recognition mode and developmental ontogeny into two types: CDR H3-dominated and VH-gene-restricted. Both could achieve greater than 80% neutralization breadth, and both could develop in the same donor. Although paratope chemistries differed, all 16 gp120-CD4bs antibody complexes showed geometric similarity, with antibody-neutralization breadth correlating with antibody-angle of approach relative to the most effective antibody of each type. The repertoire for effective recognition of the CD4 supersite thus comprises antibodies with distinct paratopes arrayed about two optimal geometric orientations, one achieved by CDR H3 ontogenies and the other achieved by VH-gene-restricted ontogenies.

摘要

HIV-1糖蛋白120(gp120)上与CD4受体结合的位点可被广泛反应性抗体识别,其中几种抗体可中和超过90%的HIV-1毒株。为了解抗体如何实现这种中和作用,我们分离出了CD4结合位点(CD4bs)抗体,并分析了来自14名供体的CD4bs抗体的16个共晶体结构——本文测定了其中8个。这16种抗体根据识别模式和发育个体发生分为两种类型:互补决定区H3(CDR H3)主导型和重链可变区(VH)基因受限型。两者都能实现大于80%的中和广度,且都可在同一供体内产生。尽管抗原结合部位的化学性质不同,但所有16种gp120-CD4bs抗体复合物都表现出几何相似性,抗体中和广度与相对于每种类型最有效的抗体的接近角度相关。因此,有效识别CD4超位点的抗体库包括具有不同抗原结合部位的抗体,这些抗原结合部位围绕两种最佳几何取向排列,一种由CDR H3个体发生实现,另一种由VH基因受限个体发生实现。

相似文献

1
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors.
Cell. 2015 Jun 4;161(6):1280-92. doi: 10.1016/j.cell.2015.05.007. Epub 2015 May 21.
2
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
Science. 2009 Nov 20;326(5956):1123-7. doi: 10.1126/science.1175868.
4
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
J Mol Biol. 2006 Mar 17;357(1):82-99. doi: 10.1016/j.jmb.2005.12.062. Epub 2006 Jan 9.
5
Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.
J Virol. 2012 May;86(10):5844-56. doi: 10.1128/JVI.07139-11. Epub 2012 Mar 14.
9
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
Nat Struct Mol Biol. 2013 Jul;20(7):796-803. doi: 10.1038/nsmb.2594. Epub 2013 May 26.
10

引用本文的文献

1
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.
J Exp Med. 2025 Oct 6;222(10). doi: 10.1084/jem.20250693. Epub 2025 Aug 12.
2
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.
Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2510163122. doi: 10.1073/pnas.2510163122. Epub 2025 Aug 11.
3
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope.
NPJ Vaccines. 2025 Aug 5;10(1):185. doi: 10.1038/s41541-025-01235-5.
5
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.
Cell Rep. 2025 Jun 24;44(6):115848. doi: 10.1016/j.celrep.2025.115848. Epub 2025 Jun 13.
8
Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-like antibodies.
PLoS Pathog. 2025 May 29;21(5):e1013039. doi: 10.1371/journal.ppat.1013039.
9
Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody.
Structure. 2025 Aug 7;33(8):1325-1336.e5. doi: 10.1016/j.str.2025.04.020. Epub 2025 May 23.
10
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.
Structure. 2025 Jul 3;33(7):1150-1164.e8. doi: 10.1016/j.str.2025.04.016. Epub 2025 May 14.

本文引用的文献

1
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.
Cell. 2015 Apr 23;161(3):470-485. doi: 10.1016/j.cell.2015.03.004. Epub 2015 Apr 9.
2
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.
Nature. 2014 Oct 23;514(7523):455-61. doi: 10.1038/nature13808. Epub 2014 Oct 8.
4
Structural insights on the role of antibodies in HIV-1 vaccine and therapy.
Cell. 2014 Feb 13;156(4):633-48. doi: 10.1016/j.cell.2014.01.052.
5
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.
AIDS. 2014 Jan 14;28(2):163-9. doi: 10.1097/QAD.0000000000000106.
6
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.
Science. 2013 Dec 20;342(6165):1484-90. doi: 10.1126/science.1245627. Epub 2013 Oct 31.
7
Crystal structure of a soluble cleaved HIV-1 envelope trimer.
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
8
De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):E4088-97. doi: 10.1073/pnas.1306262110. Epub 2013 Oct 8.
10
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies.
J Exp Med. 2013 Jun 3;210(6):1235-49. doi: 10.1084/jem.20130221. Epub 2013 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验